“I think that traditionally, most people think that prevention is early detection. Prevention is really prevention, that you actually stop the disease as it emerges.” ~ Vincent Tuohy, PhD., Lerner Research Institute
Vincent Tuohy, PhD, immunologist and 2010 Sones Innovation award winner is featured for his ground breaking work on a breast cancer vaccine. The vaccine targets a protein found in breast tumors and not in healthy breast tissue. Paul DiCorleto, PhD, Chairman, Lerner Research Institute comments on this new discovery. Dr. Tuohy has developed the first breast cancer vaccine to be proven effective in a mouse model.”
~ Cleveland Clinic
What’s the process of moving research findings into clinical trials? Estimates indicate that $6 million is needed over 5 years to obtain permission from the FDA to test our vaccine and finish Phase I clinical trials designed to determine its safety and dose requirements in women.
Dr. Vincent Tuohy, In the News
Vaccine of Hope The Huffington Post (5/2/2013)
A World Without Breast Cancer?,The Health Care Blog (3/19/11)
Sones Innovation Award Honors Breast Cancer Vaccine Research, Cleveland Clinic (3/11/11)
Dr. Tuohy Goes to Washington, LRI (8/4/10)
Breast Cancer Vaccine Research and Development: Behind the Scenes, LRI (8/2/10)
Cleveland Clinic Researchers Develop Prototype Vaccine To Prevent Breast Cancer, LRI (5/30/10)
Breast Cancer Vaccine Successful in Mice, CNN (6/1/10)
Health in the Future: Breast Cancer Vaccine, The Independent (6/1/10)
Cleveland Clinic Doctor Reports a Possible Vaccine to Prevent Breast Cancer, USA Today(6/1/10)
Breast Cancer Vaccine Shows Promising Results, CBS (5/31/10)
Breast Cancer Vaccine Trials Planned, WebMD (5/31/10)
Breast Cancer Vaccine Possible, Scientists Say, Bloomberg Businessweek (5/30/10)
Hopes for Breast Cancer Vaccine, BBC (5/31/10)
An autoimmune-mediated strategy for prophylactic breast cancer vaccination. Nature Medicine 2010; 16
